Medicare Enrolled
Dr. Laura Morgan, MD
Pulmonary Disease · Palm Desert, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Morgan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Morgan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Morgan
Dr. Laura Morgan is a pulmonary disease specialist in Palm Desert, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Morgan performed 1,969 Medicare services across 1,555 unique beneficiaries.
Between the years covered by Open Payments, Dr. Morgan received a total of $14,936 from 65 pharmaceutical and/or device companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Morgan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in CA
$14,936 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,969
Medicare services
Top 20% in CA for pulmonary disease
1,555
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
334 | $63 | $140 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
331 | $99 | $205 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
231 | $133 | $150 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
216 | $83 | $91 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
150 | $64 | $146 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
108 | $8 | $30 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
95 | $7 | $15 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
80 | $10 | $15 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
78 | $72 | $100 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
78 | $32 | $67 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
43 | $141 | $393 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
40 | $93 | $212 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $11 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $115 | $315 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $132 | $270 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
22 | $228 | $350 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
21 | $169 | $250 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
20 | $43 | $75 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
15 | $10 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
12 | $62 | $205 |
| Same-day hospital admission and discharge, high complexity Initial hospital care for a patient admitted and discharged on the same day, involving a high level of medical decision making. This service requires at least 85 minutes of time spent on the day of the visit. |
12 | $169 | $330 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,936
Total received (2018-2024)
Avg $2,134/year across 7 years
Top 12% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
663
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,734 (98.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$202 (1.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,869
2023
$1,849
2022
$2,143
2021
$2,051
2020
$1,823
2019
$2,196
2018
$3,005
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$362
Boehringer Ingelheim Pharmaceuticals, Inc.
$189
GlaxoSmithKline, LLC.
$168
Amgen Inc.
$155
Neurocrine Biosciences, Inc.
$129
Daiichi Sankyo Inc.
$124
Abbott Laboratories
$115
Mylan Specialty L.P.
$90
Grifols USA, LLC
$77
GENZYME CORPORATION
$74
Takeda Pharmaceuticals U.S.A., Inc.
$63
PFIZER INC.
$47
Baxter Healthcare
$44
Insmed, Inc.
$43
Novo Nordisk Inc
$39
Regeneron Healthcare Solutions, Inc.
$32
Astellas Pharma US Inc
$30
Exact Sciences Corporation
$20
Vifor Pharma, Inc.
$20
Paratek Pharmaceuticals, Inc.
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Lilly USA, LLC
$14
Top 3 companies account for 38.5% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,084
AstraZeneca Pharmaceuticals LP
$1,880
GlaxoSmithKline, LLC.
$1,518
Daiichi Sankyo Inc.
$782
Shire North American Group Inc
$677
Amgen Inc.
$633
Novo Nordisk Inc
$594
Takeda Pharmaceuticals U.S.A., Inc.
$537
Insmed, Inc.
$448
Mylan Specialty L.P.
$434
PFIZER INC.
$381
Genentech USA, Inc.
$363
AbbVie, Inc.
$313
Neurocrine Biosciences, Inc.
$242
Kowa Pharmaceuticals America, Inc.
$239
Philips Electronics North America Corporation
$221
Astellas Pharma US Inc
$219
Baxter Healthcare
$208
Bayer HealthCare Pharmaceuticals Inc.
$206
GENZYME CORPORATION
$199
Amarin Pharma Inc.
$198
Abbott Laboratories
$185
Allergan Inc.
$177
BioCryst US Sales Co., LLC
$157
Radius Health, Inc.
$149
E.R. Squibb & Sons, L.L.C.
$147
Grifols USA, LLC
$145
Conformis, Inc.
$144
Teva Pharmaceuticals USA, Inc.
$122
Merck Sharp & Dohme Corporation
$113
ABBVIE INC.
$96
SANOFI-AVENTIS U.S. LLC
$80
TherapeuticsMD, Inc.
$79
Regeneron Healthcare Solutions, Inc.
$70
Covis Pharma GmBH
$65
AbbVie Inc.
$63
Seqirus USA Inc
$53
ARBOR PHARMACEUTICALS, INC.
$46
Electromed, Inc.
$44
Circassia Pharmaceuticals Inc
$43
Arbor Pharmaceuticals, Inc.
$42
Paratek Pharmaceuticals, Inc.
$40
Exact Sciences Corporation
$39
Advanced Respiratory, Inc
$33
Lilly USA, LLC
$30
ADVANCED RESPIRATORY, INC
$29
Janssen Pharmaceuticals, Inc
$28
Kyowa Kirin, Inc.
$27
HOSPIRA, INC.
$26
Boston Scientific Corporation
$26
Actelion Pharmaceuticals US, Inc.
$25
Esperion Therapeutics, Inc.
$24
Pulmonx Corporation
$22
Nevro Corp.
$22
United Therapeutics Corporation
$20
Vifor Pharma, Inc.
$20
Bio Products Laboratory USA, Inc.
$18
Alfasigma USA, Inc.
$18
Sunovion Pharmaceuticals Inc.
$18
Novartis Pharmaceuticals Corporation
$17
Ultragenyx Pharmaceutical Inc.
$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Vanda Pharmaceuticals Inc.
$13
MAYNE PHARMA COMMERCIAL LLC
$5
Vertiflex, Inc.
$5
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (8876) Vest Therapy Und · (9061) SRC Sol Space · AIRSUPRA · ALVESCO · ANNOVERA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Aimovig · Arikayce · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · CINRYZE · COLOGUARD · CUTAQUIG · CUVITRU · Cologuard Collection Kit · Creon · DUPIXENT · ELIQUIS · ENTRESTO · EVENITY · Edarbi · Esbriet · FARXIGA · FASENRA · FIRAZYR · FREESTYLE LIBRE 3 · Fluad · GLASSIA · Gammaplex · HETLIOZ · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Monarch Airway Clearance System · Hillrom - Vest System Model 105 Home Care · Horizant · IMVEXXY · INGREZZA · INJECTAFER · ITotal Identity PS · JANUVIA · JARDIANCE · Kerendia · LINZESS · LONHALA MAGNAIR · Life 2000 Ventilation System · Livalo · MOUNJARO · MYRBETRIQ · NEXLETOL · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORLADEYO · Omnia · Otezla · Ozempic · PANZYGA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Proclaim Family of SCS IPGs · Prolastin-C · Prolastin-C Liquid · Prolia · Pulmonx Endobronchial Valve EBV · QVAR · RYBELSUS · Repatha · Respiratoriy Care Undiv · Rybelsus · SHINGRIX · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SPRAVATO · STIOLTO · STIOLTO RESPIMAT · SUPERION · SYMBICORT · SYNTHROID · Superion ISS · Synthroid · TAKHZYRO · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · Tymlos · UBRELVY · VIBERZI · VRAYLAR · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · Xolair · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
7
Per 100K population
0.3
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
5.5 mi
5.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Morgan is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Morgan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Morgan performed 334 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Morgan receive payments from pharmaceutical companies?
Yes. Dr. Morgan received a total of $14,936 from 65 companies across 663 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Morgan's costs compare to other pulmonary diseases in Palm Desert?
Dr. Morgan's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Morgan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Palm Desert
Browse pulmonary diseases in Palm Desert ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology